Humacyte (NASDAQ:HUMA)
Human-based tissue scaffolds, including a biological vascular graft to provide vascular access to end-stage renal disease patients who need hemodialys....
Get a Demo and See the Full Profile
Get a demo today to see profiles of Humacyte (NASDAQ:HUMA) plus 5903 other startups.
